Juan Alaix
Juan Ramón Alaix is the former Chief Executive Officer of Zoetis. During his seven-year tenure as CEO, Zoetis became the global leader in animal health, with $5.8 billion in revenue in 2018, a market capitalization of nearly $60 billion, and several groundbreaking new medicines ranked among the top products in the animal health industry. Mr. Alaix remains a member of the Zoetis Board of Directors and serves as an advisor to the company.
Mr. Alaix has 35 years’ experience of increasing responsibility in finance, sales and management, including 20 years in the pharmaceutical industry. Prior to Zoetis, he served as President of Pfizer Animal Health, where he was responsible for the overall strategic direction and financial performance of the company beginning in 2006. He joined Pfizer from Pharmacia in 2003 as regional president. In the 1990s, he served in general management with Rhône-Poulenc Rorer in Spain and Belgium before becoming country president of Spain for Pharmacia in 1998.
Mr. Alaix has served as President of the International Federation for Animal Health (IFAH), now known as HealthforAnimals from 2011-2013, in addition to serving as a member of the board and executive committee. HealthforAnimals represents manufacturers of veterinary medicines, vaccines and other animal health products in both developed and emerging markets. In 2018, he was awarded the Deming Cup for Operational Excellence from the Columbia Business School for his achievements as CEO of Zoetis.
A native of Spain, Mr. Alaix received a graduate degree in economics from the Universidad de Madrid. Areas of interest: Healthcare, management, strategic plan and budget, capital allocation, IPO, shareholder activism, corporate governance.